AnalystsRoss MukenRoss Muken's Stock Forecasts
AnalystsRoss Muken
Analyst Ranking
Top 30%
#1472 out of 4995 analysts
Average Return
+5.39%
Win Rate
70%16 out of 23
Risk vs Reward
Poor
Good
Ross Muken's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Rite Aid CorpRADCQ | +61.83% | $40.60 | $15.50 | 2018-01-05 - 2019-01-04 | Sell |
Rite Aid CorpRADCQ | +41.36% | $59.00 | $34.60 | 2017-06-30 - 2018-06-29 | Sell |
Charles River Laboratories International IncCRL | +38.01% | $79.32 | $109.47 | 2017-01-04 - 2018-01-04 | Strong Buy |
Illumina IncILMN | +37.71% | $166.82 | $229.73 | 2017-02-27 - 2018-02-27 | Strong Buy |
Illumina IncILMN | +29.92% | $232.99 | $302.69 | 2018-01-04 - 2019-01-04 | Buy |
Ross Muken Analyst Color
Get additional color on Ross Muken's coverage of popular stocks
Ross Muken's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Charles River Laboratories International IncCRL | 8 | Buy | $190.00 | +17.40% | Maintains | 16 days ago |
Henry Schein IncHSIC | 7 | Hold | $70.00 | +0.57% | Maintains | 18 days ago |
Icon PLCICLR | 6 | Buy | $240.00 | +36.50% | Maintains | a month ago |
Patterson Companies IncPDCO | 4 | Hold | $22.00 | -29.78% | Maintains | a year ago |
Agilent Technologies IncA | 10 | Hold | $130.00 | N/A | Maintains | a year ago |
Rite Aid CorpRADCQ | 2 | Sell | $30.00 | N/A | Initiates Coverage On | 8 years ago |
Cardinal Health IncCAH | 1 | Hold | $67.00 | N/A | Initiates Coverage On | 8 years ago |
Illumina IncILMN | 2 | Buy | $250.00 | N/A | Initiates Coverage On | 8 years ago |
Qiagen NvQGEN | 1 | Buy | $36.05 | N/A | Initiates Coverage On | 8 years ago |
Thermo Fisher Scientific IncTMO | 1 | Buy | $220.00 | N/A | Initiates Coverage On | 8 years ago |
Parexel International CorpPRXL | 2 | Buy | N/A | N/A | Upgrades | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.